Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-23 Sale | 2026-03-24 5:38 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,182 | $46.78 | $148,854 | 169,807 (Direct) | View |
| 2026-03-23 Sale | 2026-03-24 5:37 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 10,020 | $46.78 | $468,736 | 491,000 (Direct) | View |
| 2026-03-23 Sale | 2026-03-24 5:37 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 3,708 | $46.78 | $173,460 | 94,064 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 5:37 pm | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 3,150 | $48.26 | $152,019 | 37,518 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 5:37 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 9,869 | $48.26 | $476,278 | 43,648 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 5:35 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,450 | $48.26 | $166,497 | 111,865 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 10,349 | $48.26 | $499,443 | 307,709 (Direct) | View |
| 2026-03-11 Sale | 2026-03-12 5:35 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 2,800 | $52.8 | $147,840 | 93,315 (Direct) | View |
| 2026-03-11 Sale | 2026-03-12 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 9,798 | $52.8 | $517,334 | 254,808 (Direct) | View |
| 2026-02-19 Sale | 2026-02-20 5:36 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 6,967 | $52.58 | $366,325 | 226,106 (Direct) | View |
| 2026-02-19 Sale | 2026-02-20 5:35 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 2,112 | $52.58 | $111,049 | 85,115 (Direct) | View |
| 2025-04-03 Purchase | 2026-01-27 5:35 pm | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 1,508 | $32.96 | $49,704 | 1,508 (Direct) | View |
| 2026-01-22 Sale | 2026-01-26 5:35 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 34,972 | $60.19 | $2,104,965 | 48,434 (Direct) | View |
| 2026-01-20 Sale | 2026-01-22 5:55 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 90,000 | $57.4 | $5,166,298 | 219,823 (Indirect Direct) | View |
| 2026-01-06 Sale | 2026-01-08 5:35 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 29,700 | $60.16 | $1,786,636 | 90,899 (Direct) | View |
| 2025-12-22 Sale | 2025-12-23 5:33 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 10,000 | $55.95 | $559,549 | 6,767 (Direct) | View |
| 2025-10-17 Sale | 2025-10-20 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,895 | $67.91 | $3,456,279 | 639,863 (Indirect Direct) | View |
| 2025-10-14 Sale | 2025-10-15 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 4,242 | $66.6 | $282,517 | 299,091 (Indirect Direct) | View |
| 2025-10-14 Sale | 2025-10-15 5:35 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 1,076 | $66.6 | $71,662 | 85,515 (Direct) | View |
| 2025-08-18 Sale | 2025-08-19 4:30 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,081 | $58.15 | $760,660 | 292,626 (Indirect Direct) | View |
| 2025-08-06 Purchase | 2025-08-08 4:06 pm | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 20,000 | $57.03 | $1,140,600 | 22,000 (Direct) | View |
| 2025-07-16 Purchase | 2025-07-17 5:19 pm | CRISPR Therapeutics AG | CRSP | George Simeon Director | 989,812 | $52.03 | $51,499,918 | 1,730,179 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-20 Option Award | 2026-03-24 5:38 pm | N/A 2036-03-20 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 63,499 | $0 | 169,807 (Direct) | View |
| 2026-03-20 Exercise | 2026-03-24 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 6,250 | $0 | 169,807 (Direct) | View |
| 2026-03-20 Option Award | 2026-03-24 5:37 pm | N/A 2036-03-20 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 196,124 | $0 | 491,000 (Direct) | View |
| 2026-03-20 Exercise | 2026-03-24 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,687 | $0 | 491,000 (Direct) | View |
| 2026-03-20 Option Award | 2026-03-24 5:37 pm | N/A 2036-03-20 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 65,999 | $0 | 94,064 (Direct) | View |
| 2026-03-20 Exercise | 2026-03-24 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 6,250 | $0 | 94,064 (Direct) | View |
| 2026-03-20 Option Award | 2026-03-24 5:36 pm | N/A 2036-03-20 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 68,499 | $0 | 68,499 (Direct) | View |
| 2026-03-14 Exercise | 2026-03-17 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 8,125 | $0 | 37,518 (Direct) | View |
| 2026-03-16 Gift | 2026-03-17 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 750 | $0 | 43,648 (Direct) | View |
| 2026-03-14 Exercise | 2026-03-17 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 16,875 | $0 | 43,648 (Direct) | View |
| 2026-03-14 Exercise | 2026-03-17 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 6,875 | $0 | 111,865 (Direct) | View |
| 2026-03-14 Exercise | 2026-03-17 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,625 | $0 | 307,709 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 5,500 | $0 | 93,315 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,250 | $0 | 254,808 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-20 5:36 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,250 | $0 | 226,106 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-20 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,825 | $0 | 85,115 (Direct) | View |
| 2026-01-22 Exercise | 2026-01-26 5:35 pm | N/A 2033-03-14 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 34,972 | $0 | 48,434 (Direct) | View |
| 2026-01-22 Exercise | 2026-01-26 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 34,972 | $45.15 | 48,434 (Direct) | View |
| 2026-01-06 Exercise | 2026-01-08 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 6,339 | $44.31 | 90,899 (Direct) | View |
| 2026-01-06 Exercise | 2026-01-08 5:35 pm | N/A 2033-03-14 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 29,700 | $0 | 90,899 (Direct) | View |
| 2026-01-06 Exercise | 2026-01-08 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 23,361 | $45.15 | 90,899 (Direct) | View |
| 2025-12-18 Gift | 2025-12-22 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 30,000 | $0 | 309,823 (Direct) | View |
| 2025-10-16 Exercise | 2025-10-20 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 100,000 | $0 | 639,863 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 8,334 | $0 | 299,091 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 2,114 | $0 | 85,515 (Direct) | View |
| 2025-10-03 Option Award | 2025-10-03 5:38 pm | N/A 2035-10-03 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 49,500 | $0 | 49,500 (Direct) | View |
| 2025-10-03 Option Award | 2025-10-03 5:37 pm | N/A 2035-10-03 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 16,500 | $0 | 16,500 (Direct) | View |
| 2025-10-03 Option Award | 2025-10-03 5:36 pm | N/A 2035-10-03 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 16,500 | $0 | 16,500 (Direct) | View |
| 2025-10-03 Option Award | 2025-10-03 5:36 pm | N/A 2035-10-03 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 16,500 | $0 | 16,500 (Direct) | View |
| 2025-09-17 Gift | 2025-09-19 5:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 6,000 | $0 | 286,626 (Direct) | View |
| 2025-08-16 Exercise | 2025-08-19 4:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 292,626 (Direct) | View |
Ownership(A) | 2025-06-10 5:31 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Morrison Briggs Director | 0 | $0 | 31,209 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:47 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | George Simeon Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:38 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Morrison Briggs Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Rommel Christian Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Greene John Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Fardis Maria Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | High Katherine A Director | 13,000 | $0 | 13,000 (Direct) | View |